We are live on ! Find out more
PTC

Private Trust Company Portfolio holdings

AUM $1.25B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
+7.96%
1 Year Est. Return
+29.12%
3 Year Est. Return
+79.64%
5 Year Est. Return
+96.77%
10 Year Est. Return
+318.79%
AUM
$1.13B
AUM Growth
+$83.6M
Cap. Flow
+$13.8M
Cap. Flow %
1.22%
Top 10 Hldgs %
18.79%
Holding
2,697
New
229
Increased
795
Reduced
793
Closed
135

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.39%
2 Technology 16.35%
3 Financials 7.56%
4 Industrials 5.81%
5 Healthcare 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLKB icon
1776
Blackbaud
BLKB
$2.21B
$13.8K ﹤0.01%
215
+119
+124% +$7.79K
EXE
1777
Expand Energy Corp
EXE
$22.2B
$13.8K ﹤0.01%
130
+21
+19% +$2.11K
FBT icon
1778
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.96B
$13.8K ﹤0.01%
77
+28
+57% +$4.77K
POR icon
1779
Portland General Electric
POR
$5.86B
$13.8K ﹤0.01%
313
-1,120
-78% -$47K
VTC icon
1780
Vanguard Total Corporate Bond ETF
VTC
$1.72B
$13.7K ﹤0.01%
175
TSLX icon
1781
Sixth Street Specialty
TSLX
$1.79B
$13.7K ﹤0.01%
600
EEFT icon
1782
Euronet Worldwide
EEFT
$2.61B
$13.7K ﹤0.01%
156
THO icon
1783
Thor Industries
THO
$4.03B
$13.7K ﹤0.01%
132
-2
-1% -$201
SPBC icon
1784
Simplify US Equity PLUS GBTC ETF
SPBC
$44M
$13.6K ﹤0.01%
302
AMTM
1785
Amentum Holdings
AMTM
$5.01B
$13.6K ﹤0.01%
566
+8
+1% +$195
LNTH icon
1786
Lantheus
LNTH
$6.59B
$13.5K ﹤0.01%
264
+19
+8% +$1.19K
TAK icon
1787
Takeda Pharmaceutical
TAK
$57.6B
$13.5K ﹤0.01%
924
-111
-11% -$1.65K
RAL
1788
Ralliant Corp
RAL
$7.07B
$13.5K ﹤0.01%
+309
New +$13.7K
IDCC icon
1789
InterDigital
IDCC
$8.77B
$13.5K ﹤0.01%
39
+34
+680% +$9.24K
NOG icon
1790
Northern Oil and Gas
NOG
$2.71B
$13.4K ﹤0.01%
542
+325
+150% +$8.62K
GH icon
1791
Guardant Health
GH
$22.8B
$13.4K ﹤0.01%
214
+111
+108% +$6.04K
BBRE icon
1792
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.28B
$13.4K ﹤0.01%
140
VNT icon
1793
Vontier
VNT
$4.51B
$13.3K ﹤0.01%
316
+29
+10% +$1.19K
UNF icon
1794
Unifirst Corp
UNF
$5.16B
$13.2K ﹤0.01%
79
ADPT icon
1795
Adaptive Biotechnologies
ADPT
$4.26B
$13.2K ﹤0.01%
880
+91
+12% +$1.11K
MDST
1796
Westwood Salient Enhanced Midstream Income ETF
MDST
$295M
$13.1K ﹤0.01%
+492
New +$13.1K
ATR icon
1797
AptarGroup
ATR
$8.53B
$13.1K ﹤0.01%
98
-11
-10% -$1.59K
DIOD icon
1798
Diodes
DIOD
$4.22B
$13.1K ﹤0.01%
246
+126
+105% +$6.75K
BLFS icon
1799
BioLife Solutions
BLFS
$1.82B
$13.1K ﹤0.01%
512
-64
-11% -$1.52K
CW icon
1800
Curtiss-Wright
CW
$22.5B
$13K ﹤0.01%
24
-4
-14% -$1.97K

Similar funds

Private Trust Company's Q3 2025 Portfolio in Review

As of Q3 2025, Private Trust Company held 2,697 positions worth $1.13B, up 8% from $1.05B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Private Trust Company's Q3 2025 filing shows 229 new, 795 increased, 793 reduced and 135 closed positions. Its largest new stake was Xtrackers Artificial Intelligence and Big Data ETF: 25,175 shares worth $1.05M. The largest sale was Eli Lilly, an estimated $1.82M.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 45% a quarter earlier, followed by Technology and Financials.

  • Private Trust Company's largest Q3 2025 buy was Xtrackers Artificial Intelligence and Big Data ETF: 25,175 shares worth $1.05M.
  • Private Trust Company added most to Stryker in Q3 2025, an estimated $4.71M increase.
  • Private Trust Company's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $1.82M.
  • Private Trust Company fully exited Ansys in Q3 2025, selling an estimated $600K.
  • Private Trust Company's ten largest holdings make up 19% of its $1.13B portfolio in Q3 2025.
  • Private Trust Company opened 229 new positions and closed 135 in Q3 2025.
  • Private Trust Company's portfolio value rose 8% quarter-over-quarter to $1.13B.

Based on Private Trust Company's 13F filing for Q3 2025, filed 15 Oct 2025.